Amundi Purchases 36,299 Shares of Teleflex Incorporated (NYSE:TFX)

Amundi increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 10.3% in the 4th quarter, HoldingsChannel reports. The fund owned 389,876 shares of the medical technology company’s stock after acquiring an additional 36,299 shares during the period. Amundi’s holdings in Teleflex were worth $69,382,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Janus Henderson Group PLC raised its stake in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. State Street Corp grew its position in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC grew its position in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its position in Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Truist Financial dropped their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Morgan Stanley lowered their price target on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and reduced their price objective for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $182.63.

Teleflex Stock Performance

NYSE:TFX opened at $139.25 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a fifty day moving average of $169.58 and a two-hundred day moving average of $199.60. The stock has a market capitalization of $6.46 billion, a PE ratio of 27.68, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.90.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.